Operating Income Summary of Taiyen Biotech Co., Ltd.

Taiyen Biotech Co., Ltd.'s latest annual operating income in 2023 was 312.65 Million TWD , down -41.57% from previous year.
Taiyen Biotech Co., Ltd.'s latest quarterly operating income in 2024 Q2 was 94.03 Million TWD , up 50.03% from previous quarter.
Taiyen Biotech Co., Ltd. reported an annual operating income of 535.11 Million TWD in 2022, up 3.73% from previous year.
Taiyen Biotech Co., Ltd. reported an annual operating income of 515.86 Million TWD in 2021, up 10.31% from previous year.
Taiyen Biotech Co., Ltd. reported a quarterly operating income of 94.03 Million TWD for 2024 Q2, up 50.03% from previous quarter.
Taiyen Biotech Co., Ltd. reported a quarterly operating income of 211.47 Million TWD for 2023 Q3, up 514.38% from previous quarter.

Annual Operating Income Chart of Taiyen Biotech Co., Ltd. (2023 - 2009)

Historical Annual Operating Income of Taiyen Biotech Co., Ltd. (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	312.65 Million TWD	-41.57%
2022	535.11 Million TWD	3.73%
2021	515.86 Million TWD	10.31%
2020	467.64 Million TWD	8.52%
2019	430.94 Million TWD	2.97%
2018	418.5 Million TWD	0.1%
2017	418.08 Million TWD	2.02%
2016	409.82 Million TWD	32.5%
2015	309.29 Million TWD	87.49%
2014	164.96 Million TWD	66.14%
2013	99.29 Million TWD	107.12%
2012	47.93 Million TWD	-79.16%
2011	230.06 Million TWD	0.3%
2010	229.37 Million TWD	1.42%
2009	226.16 Million TWD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	88.49 Million TWD	1612.62%
2024 Q2	94.03 Million TWD	50.03%
2023 Q3	211.47 Million TWD	514.38%
2023 FY	312.65 Million TWD	-41.57%
2023 Q4	5.16 Million TWD	-97.56%
2023 Q1	134.65 Million TWD	9.03%
2023 Q2	34.42 Million TWD	-74.44%
2022 Q1	166.3 Million TWD	53.26%
2022 Q3	203.61 Million TWD	388.44%
2022 FY	535.11 Million TWD	3.73%
2022 Q4	123.5 Million TWD	-39.34%
2022 Q2	41.68 Million TWD	-74.93%
2021 Q2	144.14 Million TWD	11.35%
2021 Q4	108.51 Million TWD	-23.69%
2021 Q3	142.2 Million TWD	-1.35%
2021 FY	515.86 Million TWD	10.31%
2021 Q1	129.44 Million TWD	-17.91%
2020 Q2	98.42 Million TWD	1.58%
2020 Q4	157.68 Million TWD	42.94%
2020 FY	467.64 Million TWD	8.52%
2020 Q1	96.89 Million TWD	0.72%
2020 Q3	110.31 Million TWD	12.07%
2019 Q4	96.2 Million TWD	-15.54%
2019 Q1	97.15 Million TWD	27.75%
2019 Q3	113.89 Million TWD	1.24%
2019 FY	430.94 Million TWD	2.97%
2019 Q2	112.5 Million TWD	15.8%
2018 Q3	121.15 Million TWD	-2.61%
2018 Q2	124.4 Million TWD	28.39%
2018 FY	418.5 Million TWD	0.1%
2018 Q4	76.05 Million TWD	-37.23%
2018 Q1	96.89 Million TWD	49.4%
2017 Q1	107.58 Million TWD	26.19%
2017 FY	418.08 Million TWD	2.02%
2017 Q4	64.85 Million TWD	-48.86%
2017 Q3	126.8 Million TWD	6.7%
2017 Q2	118.84 Million TWD	10.47%
2016 Q1	83.69 Million TWD	72.58%
2016 Q4	85.25 Million TWD	-34.88%
2016 Q3	130.92 Million TWD	19.08%
2016 Q2	109.94 Million TWD	31.37%
2016 FY	409.82 Million TWD	32.5%
2015 Q2	91.67 Million TWD	17.22%
2015 Q3	90.91 Million TWD	-0.83%
2015 Q1	78.21 Million TWD	136.87%
2015 FY	309.29 Million TWD	87.49%
2015 Q4	48.49 Million TWD	-46.66%
2014 FY	164.96 Million TWD	66.14%
2014 Q4	33.01 Million TWD	-34.81%
2014 Q3	50.64 Million TWD	29.14%
2014 Q2	39.22 Million TWD	-6.17%
2014 Q1	41.8 Million TWD	101.63%
2013 Q1	26 Million TWD	108.21%
2013 Q2	24.18 Million TWD	-7.01%
2013 Q4	20.73 Million TWD	-26.93%
2013 FY	99.29 Million TWD	107.12%
2013 Q3	28.37 Million TWD	17.31%
2012 Q1	5.5 Million TWD	367.46%
2012 FY	47.93 Million TWD	-79.16%
2012 Q4	12.49 Million TWD	46.85%
2012 Q2	18.7 Million TWD	239.73%
2012 Q3	8.5 Million TWD	-54.54%
2011 Q3	42.14 Million TWD	10.38%
2011 Q1	151.79 Million TWD	275.47%
2011 Q2	38.18 Million TWD	-74.85%
2011 Q4	-2.05 Million TWD	-104.89%
2011 FY	230.06 Million TWD	0.3%
2010 Q2	56.18 Million TWD	-20.42%
2010 Q1	70.6 Million TWD	0.0%
2010 Q3	62.16 Million TWD	10.64%
2010 Q4	40.42 Million TWD	-34.96%
2010 FY	229.37 Million TWD	1.42%
2009 FY	226.16 Million TWD	0.0%

Peer Operating Income Comparison of Taiyen Biotech Co., Ltd.

Name	Operating Income	Operating Income Difference
Farcent Enterprise Co.,Ltd	301.31 Million TWD	-3.765%
Mao Bao Inc.	-7.05 Million TWD	4532.965%
Sanitar Co., Ltd.	288.61 Million TWD	-8.331%
Chlitina Holding Limited	1.19 Billion TWD	73.899%
Jourdeness Group Limited	30.53 Million TWD	-924.098%
Nan Liu Enterprise Co., Ltd.	184.21 Million TWD	-69.724%
Luo Lih-Fen Holding Co., Ltd.	71.78 Million TWD	-335.565%
San Neng Group Holdings Co., Ltd.	220.51 Million TWD	-41.784%
Yuen Foong Yu Consumer Products Co., Ltd.	1.12 Billion TWD	72.33%
KNH Enterprise Co., Ltd.	-485.68 Million TWD	164.374%

Global Stocks Search

Taiyen Biotech Co., Ltd. (1737.TW)

Operating Income Summary of Taiyen Biotech Co., Ltd.

Annual Operating Income Chart of Taiyen Biotech Co., Ltd. (2023 - 2009)

Historical Annual Operating Income of Taiyen Biotech Co., Ltd. (2023 - 2009)

Peer Operating Income Comparison of Taiyen Biotech Co., Ltd.